Considerations for the development of health-based surface dust cleanup criteria for beryllium

References

• ACGIH. (2009). Beryllium and compounds: threshold limit value. Cincinnati, OH: American Conference of Governmental Industrial Hygienists (ACGIH)
   Google Scholar
• Andrews JL, Kazemi H, Hardy HL. (1969). Patterns of lung dysfunction in chronic beryllium disease. Am Rev Respir Dis 100:791–800
   PubMedGoogle Scholar
• ATSDR. (2002). Toxicological profile for beryllium. Atlanta, GA: Agency for Toxic Substances and Disease Registry (ATSDR)
   Google Scholar
• Bailey RL, Thomas CA, Deubner DC, et al. (2010). Evaluation of a preventive program to reduce sensitization at a beryllium metal, oxide, and alloy production plant. J Occup Environ Med 52:505–12
   PubMed Web of Science ®Google Scholar
• Beyeler WE, Hareland WA, Durán FA, et al. (1999). Residual radioactive contamination from decommissioning. Parameter analysis. Washington, DC: U.S. Nuclear Regulatory Commission (NRC), Office of Nuclear Regulatory Research, NUREG/CR-5512, Vol. 3, SAND99-2148, pp 1--163
   Google Scholar
• Boffetta P, Fryzek JP, Mandel JS. (2012). Occupational exposure to beryllium and cancer risk: a review of the epidemiologic evidence. Crit Rev Toxicol 42:107–18
   PubMed Web of Science ®Google Scholar
• Brouwer DH. (1999). Transfer of contaminants from surface to hands: Experimental assessment of linearity of the exposure process, adherence to the skin, and area exposed during fixed pressure and repeated contact with surfaces contaminated with a powder. Appl Occup Environ Hyg 14:231–9
   PubMedGoogle Scholar
• CalEPA. (2009). Proposition 65 safe harbor levels: no significant risk levels for carcinogens and maximum allowable dose levels for chemicals causing reproductive toxicity. Sacramento, CA: Reproductive and Cancer Hazard Assessment Branch, Office Environmental Health Hazard Assessment, California Environmental Protection Agency (CalEPA)
   Google Scholar
• CalEPA. (2010). Article 7. No significant risk levels. In Title 27, California code of regulations. Sacramento, CA: California Environmental Protection Agency (CalEPA)
   Google Scholar
• Caplan KJ. (1993). The significance of wipe samples. Am Ind Hyg Assoc J 54:70–5
   Web of Science ®Google Scholar
• CDC. (2004). The health consequences of smoking. Atlanta, GA: Office of the Surgeon General, US Department Health & Human Services, Center for Disease Control and Prevention (CDC)
   Google Scholar
• Cher DJ, Deubner DC, Kelsh MA, et al. (2006). Assessment of the beryllium lymphocyte proliferation test using statistical process control. Inhal Toxicol 18:901–10
   PubMed Web of Science ®Google Scholar
• Corn M, Stein F. (1964). Mechanisms of dust resuspension. In: Surface contamination: Proceedings of symposium. Gatlinburg, TN: Pergamon Press
   Google Scholar
• Couch JR, Petersen M, Rice C, Schubauer-Berigan MK. (2011). Development of retrospective quantitative and qualitative job-exposure matrices for exposures at a beryllium processing facility. Occup Environ Med 68:361–5
   PubMed Web of Science ®Google Scholar
• Crowley J, Hamilton J, Scott K. (1949). The metabolism of carrier-free radioberyllium in the rat. J Biol Chem 177:975–84
   Google Scholar
• Cummings KJ, Deubner DC, Day GA, et al. (2007). Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers. Occup Environ Med 64:134–40
   PubMed Web of Science ®Google Scholar
• Curtis G. (1951). Cutaneous hypersensitivity due to beryllium: a study of thirteen cases. AMA Arch Dermatol Syph 64:470–82
   PubMedGoogle Scholar
• Damian P. (2011). Development of a health risk-based surface contamination cleanup standard for occupational exposure to beryllium. Toxicol Mechanism Methods 21(2):97–102
   PubMed Web of Science ®Google Scholar
• Day GA, Dufresne A, Stefaniak AB, et al. (2007). Exposure pathway assessment at a copper–beryllium alloy facility. Ann Occup Hyg 51:67–80
   PubMed Web of Science ®Google Scholar
• Day GA, Stefaniak AB, Weston A, Tinkle SS. (2006). Beryllium exposure: dermal and immunological considerations. Int Arch Occup Environ Health 79:161–4
   PubMed Web of Science ®Google Scholar
• Deubner DC, Goodman M, Iannuzzi J. (2001a). Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg 16:521–6
   PubMedGoogle Scholar
• Deubner DC, Lowney YW, Paustenbach DJ, Warmerdam J. (2001b). Contribution of incidental exposure pathways to total beryllium exposures. Appl Occup Environ Hyg 16:568–78
   PubMedGoogle Scholar
• Deubner DC, Roth HD, Levy PS. (2007). Empirical evaluation of complex epidemiologic study designs: workplace exposure and cancer. J Occup Environ Med 49:953–9
   PubMed Web of Science ®Google Scholar
• Deubner DC, Sabey P, Huang W, et al. (2011). Solubility and chemistry of materials encountered by beryllium mine and ore extraction workers: Relation to risk. J Occup Environ Med 53:1187–1193
   PubMed Web of Science ®Google Scholar
• DOE. (1999). Chronic beryllium disease prevention program: final rule. Washington DC: Office of Environment Safety and Health, Department of Energy (DOE)
   Google Scholar
• DOE. (2001). Implementation Guide for use with 10 CFR Part 850, chronic beryllium disease prevention program. Oak Ridge, TN: U.S. Department of Energy (DOE), Office of Environment, Safety and Health
   Google Scholar
• DOE. (2011). 2011–2020 strategic plan. Washington, DC: U.S. Department of Energy (DOE)
   Google Scholar
• Donovan E, Kolanz M, Galbraith D, et al. (2007). Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program. Int Arch Occup Environ Health 81:165–78
   PubMed Web of Science ®Google Scholar
• Dragun J, Chiasson A. (1991). Elements in North American soils. Greenbelt, MD: Hazardous Materials Control Resources Institute
   Google Scholar
• Dufay SK, Archuleta M. (2006). Comparison of collection efficiencies of sampling methods for removable beryllium surface contamination. J Environ Monitor 8:630–3
   PubMed Web of Science ®Google Scholar
• Dufresne A, Mocanu T, Viau S, et al. (2011). Efficacy of surface sampling methods for different types of beryllium compounds. J Environ Monitor 13:74–8
   Google Scholar
• Eisenbud M, Berghout CF, Steadman LT. (1948). Environmental studies in plants and laboratories using beryllium: the acute disease. J Ind Hyg Toxicol 30:281–5
   PubMedGoogle Scholar
• Eisenbud M, Blatz H, Barry EV. (1954). How important is surface contamination? Nucleonics 12:12–15
   Google Scholar
• Eisenbud M, Wanta R, Dustan C, et al. (1949). Non-occupational berylliosis. J Ind Hyg Toxicol 31:282–94
   PubMedGoogle Scholar
• Emond C, Robin JP, Breton R, et al. (2007). Dermal exposure to beryllium: a pilot case study. J Toxicol Environ Health A 70:529–33
   PubMed Web of Science ®Google Scholar
• EPOW. (2008). Study into the feasibility of protecting and recovering critical raw materials through infrastructure development in the south east of England. Reading, UK: European Pathway to Zero Waste (EPOW) Environmental Agency
   Google Scholar
• Epstein W. (1971). Methal-induced granulomatous hypersensitivity in man. Adv Biol Skin 11:313–35
   Google Scholar
• Epstein W. (1991). Cutaneous effects of beryllium. In: Beryllium biomedical and environmental aspects. Rossman M, Preuss O, Powers M, eds. Baltimore, MD: Williams & Wilkins. pp 113--120
   Google Scholar
• FDEP. (2005). Technical report: development of cleanup target levels (CTLs) for chapter 62–777, F.A.C. Gainesville, FL: Division of Waste Management, Florida Department of Environmental Protection (FDEP)
   Google Scholar
• Furchner J, Richmond C, London J. (1973). Comparative metabolism of radionuclides in mammals. VIII. Retention of beryllium in the mouse, rat, monkey and dog. Health Phys 24:293–300
   PubMed Web of Science ®Google Scholar
• Greene J, Brorby G, Warmerdam J, Paustenbach D. (2004). Surface dust criteria for dioxin and dioxin-like compounds for re-entry to buildings. Risk Manag Reg Aspects 66:3442–8
   Google Scholar
• Hanifin JM, Epstein WL, Cline MJ. (1970). In vitro studies on granulomatous hypersensitivity to beryllium. J Invest Dermatol 554:284–8
   Google Scholar
• Henneberger PK, Cumro D, Deubner DD, et al. (2001). Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health 74:167–76
   PubMed Web of Science ®Google Scholar
• Henneberger PK, Goe SK, Miller WE, et al. (2004). Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed. J Occup Environ Hyg 1:648–59
   PubMed Web of Science ®Google Scholar
• Hinds WC. (1982). Aerosol technology: properties, behavior, and measurement of airborne particles. New York: John Wiley & Sons, Inc
   Google Scholar
• Hinds WC. (1999). Aerosol technology: properties, behavior, and measurement of airborne particles. 2nd ed. New York: John Wiley & Sons, Inc
   Google Scholar
• Hinton TG, Kopp P, Ibrahim S, et al. (1995). Comparison of technique used to estimate the amount of resuspended soil on plant surfaces. Health Physics 68:523–53
   PubMedGoogle Scholar
• Hollins DM, McKinley MA, Williams C, et al. (2009). Beryllium and lung cancer: a weight of evidence evaluation of the toxicological and epidemiological literature. Crit Rev Toxicol 39:1–32
   PubMed Web of Science ®Google Scholar
• Honeywell. (2010). Final Air sampling report for beryllium air sampling demonstration project. Kansas City, MI: Kansas City Plant
   Google Scholar
• Hoover MD, Castorina BT, Finch GL, Rothenberg SJ. (1989). Determination of the oxide layer thickness on beryllium metal particles. Am Indust Hyg Assoc J 50:550–3
   PubMed Web of Science ®Google Scholar
• Huang W, Fernandez D, Rudd A, et al. (2011). Dissolution and nanoparticle generation behavior of Be-associated materials in synthetic lung fluid using inductively coupled plasma mass spectroscopy and flow field-flow fractionation. J Chromatogr A 1218:4149–59
   PubMed Web of Science ®Google Scholar
• Hyslop F, Palmes E, Alford W, et al. (1943). The toxicology of beryllium. Natl Inst Health Bull 181:1–56
   Google Scholar
• IARC. (2002). Monographs on the evaluation of carinogenic risks to humans – Volume 83 – tobacco smoke and involuntary smoking. Lyon, France: International Agency for Research on Cancer (IARC)
   Google Scholar
• Infante PF, Wagoner JK, Sprince NL. (1980). Mortality patterns from lung cancer and nonneoplastic respiratory disease among white males in the beryllium case registry. Environ Res 21:35–43
   PubMed Web of Science ®Google Scholar
• Ivannikov AT, Popov BA, Parfenova IM. (1982). [Resorption of soluble beryllium compounds through the injured skin]. Gig Tr Prof Zabol 9:50–2
   Google Scholar
• Jaskula B. (2011). Mineral commodities summary – beryllium. Reston, VA: U.S. Geological Survey
   Google Scholar
• Kim N, Hawley J. (1985). Re-entry guidelines Binghamton State office building, Albany, NY Bureau of Toxic Substance Assessment, Division of Environmental Health Assessment, New York State Department of Health
   Google Scholar
• Kissel S, Shira J, Richter K, Fenske R. (1998). Investigation of dermal contact with soil in controlled trials. J Soil Contamination 7:737–752
   Google Scholar
• Klein R, Schwenk M, Heinrich-Ramm R, Templeton D. (2004). Diagostic relevance of the lymphocyte transformation test for sensitization to beryllium and other metals. Pure Appl Chem 76:1269–81
   Web of Science ®Google Scholar
• Kolanz ME, Madl AK, Kelsh MA, et al. (2001). A comparison and critique of historical and current exposure assessment methods for beryllium: Implications for evaluating risk of chronic beryllium disease. Appl Occup Environ Hyg 16:593–614
   PubMedGoogle Scholar
• Kreiss K, Day GA, Schuler CR. (2007). Beryllium: a modern industrial hazard. Ann Rev Public Health 28:259–77
   PubMed Web of Science ®Google Scholar
• Kreiss K, Miller F, Newman LS, et al. (1994). Chronic beryllium disease–from the workplace to cellular immunology, molecular immunogenetics, and back. Clin Immunol Immunopathol 71:123–9
   PubMedGoogle Scholar
• Kreiss K, Mroz MM, Newman LS, et al. (1996). Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3. Am J Ind Med 30:16–25
   PubMed Web of Science ®Google Scholar
• Kreiss K, Mroz MM, Zhen B, et al. (1997). Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med 54:605–12
   PubMed Web of Science ®Google Scholar
• Kreiss K, Wasserman S, Mroz MM, Newman LS. (1993). Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Environ Med 35:267–75
   Google Scholar
• Kuusisto S, Lindroos O, Rantio T, et al. (2007). PCB contaminated dust on indoor surfaces – health risks and acceptable surface concentrations in residential and occupational settings. Chemosphere 67:1194–201
   PubMed Web of Science ®Google Scholar
• Levy PS. (2002). Beryllium and lung cancer: a reanalysis of a NIOSH cohort mortality study. Inhalation Toxicol 14:1003–15
   PubMed Web of Science ®Google Scholar
• Levy PS, Roth HD, Deubner DC. (2007). Exposure to beryllium and occurrence of lung cancer: a reexamination of findings from a nested case-control study. J Occup Environ Med 49:96–101
   PubMed Web of Science ®Google Scholar
• Lioy P, Freeman N, Millette J. (2002). Dust: a metric for use in residential and building exposure assessment and source characterization. Environ Health Perspect 110:969–83
   PubMed Web of Science ®Google Scholar
• MacMahon B. (1994). The epidemiological evidence on the carcinogenicity of beryllium in humans. J Occup Med 36:15–24
   PubMedGoogle Scholar
• Madl AK, Unice K, Brown JL, et al. (2007). Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant. J Occup Environ Hyg 4:448–66
   PubMed Web of Science ®Google Scholar
• Maier LA. (2002). Clinical approach to chronic beryllium disease and other nonpneumoconiotic interstitial lung diseases. J Thoracic Imag 17:273–84
   Google Scholar
• Mancuso TF. (1979). Occupational lung cancer among beryllium workers. Proceedings of the conference on occupational exposure to fibrous and particulate dust and their extension into the environment. In: Lemen R, Dement J, eds. Dusts and disease. Park Forest South, IL: Pathotox Publishers, Inc, pp 463--482
   Google Scholar
• Mancuso TF. (1980). Mortality study of beryllium industry workers' occupational lung cancer. Environ Res 21:48–55
   PubMed Web of Science ®Google Scholar
• McCanlies E, Schuler C, Kreiss K, et al. (2007). TNFa polymorphisms in chronic beryllium disease and beryllium sensitization. J Occup Environ Med 49:446–52
   PubMed Web of Science ®Google Scholar
• McCanlies EC, Ensey JS, Schuler CR, et al. (2004). The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. Am J Ind Med 46:95–103
   PubMed Web of Science ®Google Scholar
• McNeil D. (2005). Beryllium. In: Roskill (Roskill Report), London, UK: Roskill Information Services
   Google Scholar
• Michaud J, Huntley S, Sherer R, et al. (1994). PCB and dioxin re-entry criteria for building surfaces and air. J Expos Anal Environ Epidemiol 4:197–227
   PubMedGoogle Scholar
• Morgareidge K, Cox GE, Gallo MA. (1976). Chronic feeding studies with beryllium in dogs. Submitted to Aluminum Company of America, Alcan Research & Development, Ltd., Kawecki-Berylco Industries, Inc., Brush-Wellman, Inc., Waverly, NY: Food and Drug Research Laboratories, Inc
   Google Scholar
• Mroz MM, Maier LA, Strand M, et al. (2009). Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Ind Med 52:762–73
   PubMedGoogle Scholar
• Mullen A, Stanley R, Lloyd S, Moghissi A. (1972). Radioberyllium metabolism by the dairy cow. Health Phys 22:17–22
   Google Scholar
• Newman LS. (2007). Immunotoxicology of beryllium lung disease. Environ Health Prevent Med 12:161–4
   PubMedGoogle Scholar
• Newman LS, Kreiss K, King TE Jr, et al. (1989). Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis 139:1479–86
   PubMed Web of Science ®Google Scholar
• Newman LS, Mroz MM, Balkissoon R, Maier LA. (2005). Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 171:54–60
   PubMed Web of Science ®Google Scholar
• Newman LS, Mroz MM, Maier LA, et al. (2001). Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med 433:231–7
   Google Scholar
• NIOSH. (2011). Preventing sensitization and disease from beryllium exposure. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health (NIOSH)
   Google Scholar
• NRC. (1992). Residual radioactive contamination from decomissioning. Washington, DC: U.S. Nuclear Regulatory Commission (NRC), Division of Regulatory Applications, Office of Nuclear Regulatory Research
   Google Scholar
• NRC. (2002). Re-evaluation of the indoor resuspension factor for the screening analysis of the building occupancy scenario for NRC's license termination rule. Washington, DC: U.S. Nuclear Regulatory Commission (NRC), Office of Nuclear Regulatory Research
   Google Scholar
• NRC. (2007). Health effects of beryllium exposure: a literature review. Washington DC: Committee on Beryllium Alloy Exposures, Committee on Toxicology, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council (NRC)
   Google Scholar
• NRC. (2008). Managing health effects of beryllium exposure. Washington, DC: Committee on Beryllium Alloy Exposures, Committee on Toxicology, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council (NRC)
   Google Scholar
• NYSDOH. (2002). Binghamton state office building: Post-occupancy environmental sampling, final round. Troy, NY: Center of Environmental Health, New York State Department of Health (NYSDOH)
   Google Scholar
• Paull J. (1997). A proposed risk-based model for the evaluation of surface contamination, and the assessment of potential dermal exposure. In: Doctoral Thesis of J.M. Paull, edited by School of Hygiene and Public Health, edited by School of Hygiene and Public Health. Baltimore, MD: Johns Hopkins University
   Google Scholar
• Paustenbach DJ, Finley BL, Long TF. (1997). The critical role of house dust in understanding the hazards posed by contaminated soils. Intl J Toxicol 16:339–62
   Web of Science ®Google Scholar
• Reeves A. (1965). The absorption of beryllium from the gastrointestinal tract. Arch Environ Health 11:209–14
   PubMed Web of Science ®Google Scholar
• Ribeiro M, Fritscher LG, Al-Musaed AM, et al. (2011). Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada. Lung 189:233–41
   PubMed Web of Science ®Google Scholar
• Richeldi L, Sorrentino R, Saltini C. (1993). HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262:242–4
   PubMed Web of Science ®Google Scholar
• Rodes C, Newsome R, Vanderpool R, et al. (2001). Experimental methodologies and preliminary transfer factor data for estimation of dermal exposures to particles. J Expos Anal Environ Epidemiol 11:123–39
   PubMedGoogle Scholar
• Rosenman K, Hertzberg V, Rice C, et al. (2005). Chronic beryllium disease and sensitization at a beryllium processing facility. Environ Health Perspect 113:1366–72
   PubMed Web of Science ®Google Scholar
• Rosenman K, Rossman M, Hertzberg V, et al. (2011). HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity. Occup Environ Med 68:487–93
   Google Scholar
• Rossman M. (1996). Chronic beryllium disease: diagnosis and management. Environ Health Perspect 104:945–7
   PubMed Web of Science ®Google Scholar
• Rossman M, Kern J, Elias J, et al. (1988). Proliferative response of bronchoalveolar lymphocytes to beryllium: a test for chronic beryllium disease. Ann Int Med 108:687–93
   PubMed Web of Science ®Google Scholar
• Rothman K, Mosquin P. (2011). Confounding after risk-set sampling in the beryllium study of Sanderson et al. Ann Epidemiol 21:773–9
   PubMed Web of Science ®Google Scholar
• Sackett HM, Maier LA, Silveira LJ, et al. (2004). Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J Occup Environ Med 46:953–61
   PubMed Web of Science ®Google Scholar
• Saltini C, Winestock K, Kirby M, et al. (1989). Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 320:1103–9
   PubMed Web of Science ®Google Scholar
• Sanderson WT, Henneberger PK, Martyny J, et al. (1999). Beryllium contamination inside vehicles of machine shop workers. Am J Ind Med 1:72–4
   Google Scholar
• Sanderson WT, Leonard S, Ott D, et al. (2008). Beryllium surface levels in a military ammunition plant. J Occup Environ Hyg 5:475–81
   PubMed Web of Science ®Google Scholar
• Sanderson WT, Ward EM, Steenland K, Petersen MR. (2001). Lung cancer case-control study of beryllium workers. Am J Ind Med 39:133–44
   PubMed Web of Science ®Google Scholar
• Santo Tomas LH. (2009). Beryllium hypersensitivity and chronic beryllium lung disease. Curr Opinion Pulmonary Med 15:165–9
   Google Scholar
• Sawyer RT, Dobis DR, Goldstein M, et al. (2005). Beryllium-stimulated reactive oxygen species and macrophage apoptosis. Free Radic Biol Med 38:928–37
   PubMed Web of Science ®Google Scholar
• Schubauer-Berigan MK, Couch JR, Petersen MR, et al. (2011a). Cohort mortality study of workers at seven beryllium processing plants: Update and associations with cumulative and maximum exposure. Occup Environ Med 68:345–53
   PubMed Web of Science ®Google Scholar
• Schubauer-Berigan MK, Deddens JA, Couch JR, Petersen MR. (2011b). Risk of lung cancer associated with quantitative beryllium exposure metrics within an occupational cohort. Occup Environ Med 68:354–60
   PubMed Web of Science ®Google Scholar
• Schubauer-Berigan MK, Deddens JA, Steenland K, et al. (2008). Adjustment for temporal confounders in a reanalysis of a case-control study of beryllium and lung cancer. Occup Environ Med 65:379–83
   PubMed Web of Science ®Google Scholar
• Schuler CR, Kent MS, Deubner DC, et al. (2005). Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med 47:195–205
   PubMed Web of Science ®Google Scholar
• Schuler CR, Virji MA, Deubner DC, et al. (2012). Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers. Scand J Work Environ Health 38:270–81
   PubMed Web of Science ®Google Scholar
• Scott BL, Wang Z, Marrone BL, Sauer NN. (2003). Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study. J Inorg Biochem 94:5–13
   PubMed Web of Science ®Google Scholar
• Sehmel G. (1980). Particle resuspension: a review. Environ Intl 4:107–27
   Google Scholar
• Shoaf MB, Shirai JH, Kedan G, et al. (2005). Adult dermal sediment loads following clam digging in tide flats. J Soil Contam 14:463–70
   Web of Science ®Google Scholar
• Silver K, Sharp R. (2006). Ethical considerations in testing workers for the -Glu69 marker of genetic susceptibility to chronic beryllium disease. J Occup Environ Med 48:434–43
   Web of Science ®Google Scholar
• Stanton ML, Henneberger PK, Kent MS, et al. (2006). Sensitization and chronic beryllium disease among workers in copper–beryllium distribution centers. J Occup Environ Med 48:204–11
   PubMed Web of Science ®Google Scholar
• Steenland K, Ward E. (1991). Lung cancer incidence among patients with beryllium disease: a cohort mortality study. J Natl Cancer Inst 83:1380–5
   PubMed Web of Science ®Google Scholar
• Stefaniak AB. (2011). Letter to the editor, comment on Strupp papers on beryllium metal toxicity. Ann Occup Hyg 55:556–7
   Google Scholar
• Stefaniak AB, Brink CA, Dickerson RM, et al. (2007). A theoretical framework for evaluating analytical digestion methods for poorly soluble particulate beryllium. Anal Bioanal Chem 387:2411–17
   PubMed Web of Science ®Google Scholar
• Stefaniak AB, Hoover MD, Day GA, et al. (2004). Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease. J Environ Monit 6:523–32
   PubMed Web of Science ®Google Scholar
• Stefaniak AB, Hoover MD, Dickerson RM, et al. (2003). Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease. AIHA J 64:297–305
   Web of Science ®Google Scholar
• Stefaniak AB, Virji MA, Day GA. (2011a). Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid. Chemosphere 83:1181–7
   PubMed Web of Science ®Google Scholar
• Stefaniak AB, Virji MA, Day GA. (2011b). Release of beryllium from beryllium-containing materials in artificial skin surface film liquids. Ann Occup Hyg 55:57–69
   PubMed Web of Science ®Google Scholar
• Stephan CH, Sauve S, Fournier M, Brousseau P. (2009). Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity. J Appl Toxicol 29:27–35
   Google Scholar
• Strupp C. (2010a). Beryllium metal I. Experimental results on acute oral toxicity, local skin and eye effects, and genotoxicity. Ann Occup Hyg 55:30–42
   Google Scholar
• Strupp C. (2010b). Beryllium metal II. A review of the available toxicity data. Ann Occup Hyg 55:43–56
   Google Scholar
• Thatcher TL, Layton DW. (1995). Deposition, resuspension, and penetration of particles within a residence. Atmos Environ 29:1487–97
   Web of Science ®Google Scholar
• Thatcher TL, Lunden MM, Revzan KL, et al. (2003). A concentration rebound method for measuring particle penetration and deposition in the indoor environment. Aerosol Sci Technol 37:847–64
   Web of Science ®Google Scholar
• Tinkle SS, Antonini JM, Rich BA, et al. (2003). Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 111:1202–8
   PubMed Web of Science ®Google Scholar
• USEPA. (2011). Exposure factors handbook: (2011) Edition. EPA/600/R-09/052F. Washington, DC: National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency (US EPA)
   Google Scholar
• USEPA. (2012). Regional screening table user's guide. United States Environmental Protection Agency (US EPA), Region 3, Mid-Atlantic Risk Assessment. Available from: http://www.epa.gov/reg3hwmd/risk/human/rb-concentration_table/usersguide.htm [last accessed 6 Dec (2012)]
   Google Scholar
• USACE. (2008). Source term model for fine particle resuspension from indoor surfaces. In: Construction research engineering laboratory, Kim Y, Gidwani A, Sippola M Sohn C, eds. Washington, DC: U.S. Army Corps of Engineers (USACE), Engineer and Research Development Center. ERDC/CERL TR-08-4, pp 1--65
   Google Scholar
• USEPA. (1987). Health assessment document for beryllium. Washington, DC: Office of Health and Environmental Assessment, US Environmental Protection Agency (USEPA)
   Google Scholar
• USEPA. (1989). Risk assessment guidance for superfund (RAGS), Volume I: human health evaluation manual (part A), Interim final. EPA/540/1–89–002. Washington, DC: Office of Emergency and Remedial Response, United States Environmental Protection Agency (USEPA)
   Google Scholar
• USEPA. (1997). Standard operating procedures (SOPs) for residential exposure assessments. Washington, DC: The Residential Exposure Assessment Work Group for the US Environmental Protection Agency (USEPA)
   Google Scholar
• USEPA. (1998). Toxic review of beryllium and compounds. In support of summary information on the Integrated Risk Information System (IRIS). Washington, DC: US Environmental Protection Agency (USEPA)
   Google Scholar
• USEPA. (2001). Science advisory council for exposure. Policy number 12 on recommended revisions to the standard operating procedures (SOPs) for residential exposure assessments. Washington, DC: US Environmental Protection Agency (USEPA)
   Google Scholar
• USEPA. (2003). World Trade Center indoor environment assessment: Selecting contaminants of potential concern and setting health-based benchmarks. Washington, DC: Contaminants of Potential Concern (COPC) Committee of the World Trade Center Indoor Air Task Force Working Group, US Environmental Protection Agency (USEPA)
   Google Scholar
• USEPA. (2004). Risk assessment guidance for superfund Volume I: Human health evaluation manual (Part E, Supplemental guidance for dermal risk assessment). Washington, DC: Office of Superfund Remediation and Technology Innovation, US Environmental Protection Agency (USEPA)
   Google Scholar
• USEPA. (2005). World Trade Center residential dust cleanup program. New York, NY: New York City Response and Recovery Operations, United States Environmental Protection Agency, Region 2 (USEPA)
   Google Scholar
• USEPA. (2008). Toxicological review of beryllium and compounds. Washington, DC: Integrated Risk Information System (IRIS), US Environmental Protection Agency (USEPA)
   Google Scholar
• USEPA. (2009a). Exposure factors handbook. Washington, DC: Office of Emergency and Remedial Response, US Environmental Protection Agency (USEPA)
   Google Scholar
• USEPA. (2009b). Risk assessment guidance for superfund (RAGS), volume I: human health evaluation manual (Part F, Supplemental Guidance for Inhalation Risk Assessment) EPA-540-R-070–002. Washington, DC: Office of Superfund Remediation and Technology Innovation, United States Environmental Protection Agency (USEPA)
   Google Scholar
• VanOrdstrand H, Hughes R, DeNardi J. (1945). Beryllium poisoning. J Am Med Assoc 129:1084–90
   PubMed Web of Science ®Google Scholar
• Wagoner JK, Infante PF, Bayliss DL. (1980). Beryllium: an etiologic agent in the induction of lung cancer, nonneoplastic respiratory disease, and heart disease among industrially exposed workers. Environ Res 21:15–34
   PubMed Web of Science ®Google Scholar
• Walker RL, Fish BR. (1964). Adhesion of radioactive glass particles to solid surfaces. In: Surface contamination: proceedings of a symposium, Gatlinburg, TN: Pergamon Press. p 61
   Google Scholar
• Wang Z, Farris GM, Newman LS. (2001). Beryllium sensitivity is linked to HLA-DP genotype. Toxicology 165:27–38
   Google Scholar
• Ward E, Okun A, Ruder A, et al. (1992). A mortality study of workers at seven beryllium processing plants. Am J Ind Med 22:885–904
   PubMed Web of Science ®Google Scholar
• Welch L, Ringen K, Bingham E, et al. (2004). Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites. Am J Indust Med 46:207–18
   PubMed Web of Science ®Google Scholar
• WHO. (1990). Beryllium. In: Environmental health criteria 106. Geneva, Switzerland: International Programme on Chemical Safety, World Health Organization (WHO)
   Google Scholar
• Williams W, Williams W, Kelland D, et al. (1987). Beryllium skin disease. Proceedings from the 11th World Conference on Sarcoidosis. Milan, Italy: Elsevier Press
   Google Scholar
• Williams WJ. (1996). United Kingdom beryllium registry: mortality and autopsy study. Environ Health Perspect 104:949–51
   PubMedGoogle Scholar